FORGROWTH NAP B.V. sold 1.4% of their position (157.23K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market
Open‑market sale worth $4.07M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/20/2024ACC: 0000950170-24-139069
10% Owner
Since Jan 2024
-157.23K
Net shares
Net seller
$4.07M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
157.23K disposed
Non-Derivative Transactions3
Ordinary Shares
Indirect
Shares
−54.52K
Price / share
$25.72
Trade value
$1.40M
% of position
0.5%
12/18/2024
11.01M→10.95M
Ordinary Shares
Indirect
Shares
−46.21K
Price / share
$26.55
Trade value
$1.23M
% of position
0.4%
12/18/2024
10.95M→10.91M
Ordinary Shares
Indirect
Shares
−56.51K
Price / share
$25.45
Trade value
$1.44M
% of position
0.5%
12/19/2024
10.91M→10.85M
Total
Net shares
−157.23K
Net value
-$4.07M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 12/18/2024 | S · Sale | −54.52K | $25.72 | $1.40M | 0.5% | 11.01M | 10.95M |
| Ordinary Shares Indirect | 12/18/2024 | S · Sale | −46.21K | $26.55 | $1.23M | 0.4% | 10.95M | 10.91M |
| Ordinary Shares Indirect | 12/19/2024 | S · Sale | −56.51K | $25.45 | $1.44M | 0.5% | 10.91M | 10.85M |
| Total | −157.23K | -$4.07M | ||||||
Derivative Transactions0
No derivative transactions reported